{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Healthy Enterprise","title":"MONEY BALL Episode 2 - Robert Boyce, Plakous Therapeutics","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/bc6ebfdb\"></iframe>","width":"100%","height":180,"duration":1679,"description":"This episode is part of a limited series called Money Ball in conjunction with the BLPN Club . BLPN's Money Ball program helps founders step up to the plate and knock fundraising out of the park. You'll hear about the people, their ventures, and their pitch-making experiences.In this episode, Rob Boyce, CEO of Plakous Therapeutics, discusses the company's mission to develop regenerative medicine solutions for necrotizing enterocolitis (NEC), a devastating disease affecting premature infants. He shares insights into the challenges of developing treatments for this vulnerable population, the importance of funding, and the role of networking in the biotech industry. Rob also highlights a case study of a patient named Laurel, illustrating the potential impact of their product on improving outcomes for babies at risk of NEC.Chapters:00:00 Introduction to Plakous Therapeutics01:08 Understanding Necrotizing Enterocolitis (NEC)04:23 The Genesis of Plakous Therapeutics06:24 Innovative Approach to Treatment09:27 Real-Life Impact: Case Study of Laurel13:32 Navigating the Funding Landscape16:06 Refining the Pitch Process22:05 Challenges in the Current Investment Climate25:11 Current Stage and Future PlansGuest Information:Guest's Name: Robert BoyceGuest's Title/Position:  Chief Executive OfficerGuest's Linkedin:https://www.linkedin.com/in/robertwboyce/Company / Affiliation: Plakous Therapeutics https://www.plakoustherapeutics.com/Guest's Bio:  Rob Boyce is the CEO of Plakous Therapeutics, Rob has been working in healthcare and life sciences throughout his career. He has been part of several start-up companies. Prior to Plakous Rob was at Imago Systems, Inc., a software as a service medical diagnostic company seeking to redefine the medical imaging. He started his business career at Johnson & Johnson, marketing the Tylenol Brand. While at J&J he led worldwide Sales and Marketing for Independence Technology, a Johnson & Johnson company specializing in state-of-the-art...","thumbnail_url":"https://img.transistorcdn.com/WKku9MQ84q-0q9Awqd5xdS4eoTolo1ocic6_1x8xlF0/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mMjI4/MDliNWYyM2MxYWFi/NTkwZmIwNzJkYjk2/YjliMy5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}